Success Metrics

Clinical Success Rate
90.9%

Based on 10 completed trials

Completion Rate
91%(10/11)
Active Trials
1(6%)
Results Posted
30%(3 trials)
Terminated
1(6%)

Phase Distribution

Ph phase_3
2
11%
Ph phase_1
1
6%
Ph not_applicable
7
39%
Ph phase_4
3
17%
Ph phase_2
4
22%

Phase Distribution

1

Early Stage

4

Mid Stage

5

Late Stage

Phase Distribution17 total trials
Phase 1Safety & dosage
1(5.9%)
Phase 2Efficacy & side effects
4(23.5%)
Phase 3Large-scale testing
2(11.8%)
Phase 4Post-market surveillance
3(17.6%)
N/ANon-phased studies
7(41.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

83.3%

10 of 12 finished

Non-Completion Rate

16.7%

2 ended early

Currently Active

1

trials recruiting

Total Trials

18

all time

Status Distribution
Active(1)
Completed(10)
Terminated(2)
Other(5)

Detailed Status

Completed10
unknown5
Recruiting1
Terminated1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
1
Success Rate
90.9%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (5.9%)
Phase 24 (23.5%)
Phase 32 (11.8%)
Phase 43 (17.6%)
N/A7 (41.2%)

Trials by Status

recruiting16%
unknown528%
terminated16%
completed1056%
withdrawn16%

Recent Activity

1 active trials
Showing 5 of 18
withdrawnphase_2

Terbutaline Sulfate in Adults With Asthma

NCT04973345
recruitingnot_applicable

Hot Flashes and Neurovascular Function in Women

NCT05193968
unknownphase_2

The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia

NCT05494307
completed

In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline

NCT04468568
completednot_applicable

Acute Tocolysis With Terbutaline for Suspected Fetal Distress

NCT05326269
View all 18 trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT04973345Phase 2

Terbutaline Sulfate in Adults With Asthma

Withdrawn
NCT05193968Not Applicable

Hot Flashes and Neurovascular Function in Women

Recruiting
NCT05494307Phase 2

The Combination of Terbutaline and Danazol as the Treatment of Corticosteroid-resistant/Relapse Immune Thrombocytopenia

Unknown
NCT04468568

In Utero Repair of Myelomeningocele: Atosiban Versus Terbutaline

Completed
NCT05326269Not Applicable

Acute Tocolysis With Terbutaline for Suspected Fetal Distress

Completed
NCT03106753Phase 4

Success of External Cephalic Version Study

Terminated
NCT04481282Phase 2

The Combination of Terbutaline and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Unknown
NCT03565302Not Applicable

Beta2-adrenergic Agonism and Muscle Remodelling

Unknown
NCT02557581Not Applicable

cAMP Signaling and Muscle Adaptations

Unknown
NCT02712658Not Applicable

Role of K+ and Ca2+ in Development of Muscle Fatigue

Completed
NCT00607503Phase 1

A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 Diabetes

Completed
NCT01651962Phase 4

Intravenous Terbutaline to Facilitate Labor Epidural Catheter Placement

Unknown
NCT00849095Phase 3

Prn Budesonide/Formoterol Versus Regular Budesonide/Formoterol Plus Prn Terbutaline in Mild-Moderate Asthma

Completed
NCT00974051Not Applicable

Use of Terbutaline or a Reduction in Basal Insulin in the Prevention of Nocturnal Hypoglycemia

Completed
NCT00124995Phase 4

Trial of Terbutaline for the Treatment of Status Asthmaticus in Children

Completed
NCT00989833Phase 2

Comparing Symbicort® As-Needed or Bricanyl As-Needed or Pulmicort® Once Daily + Bricanyl As-Needed in Asthma Patients

Completed
NCT00185887Not Applicable

Nitroglycerin Versus Terbutaline for Intrapartum Fetal Resuscitation

Completed
NCT00259766Phase 3

SHARE - Symbicort and Health Economics in a Real Life Evaluation

Completed

All 18 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
18